ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,298Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 252

$404K Total Retail Price of All Prescriptions

Rank: 130 out of 252

427 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,952 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 578 495 1 1
HYDROCHLOROTHIAZIDE 405 361 2 13
CARVEDILOL 361 306 3 22
LOSARTAN POTASSIUM 306 266 4 24
SIMVASTATIN 297 241 5 2
OMEPRAZOLE 294 223 6 6
AMLODIPINE BESYLATE 269 229 7 4
CITALOPRAM HBR 242 169 8 15
FUROSEMIDE 238 223 9 7
POTASSIUM CHLORIDE 236 199 10 8
METFORMIN HCL 219 129 11 9
SPIRONOLACTONE 191 152 12 53
ISOSORBIDE MONONITRATE ER 178 142 13 50
PRAVASTATIN SODIUM 177 153 14 12
GABAPENTIN 173 111 15 11
LISINOPRIL 167 116 16 3
BYSTOLIC 159 156 17 99
MIRTAZAPINE 137 82 18 58
METOPROLOL TARTRATE 137 104 18 10
WARFARIN SODIUM 136 110 20 14
HYDROCODONE-ACETAMINOPHEN 120 62 S3 21 5
ESTRADIOL 116 50 R 22 76
TRAMADOL HCL 110 93 23 17
LOSARTAN-HYDROCHLOROTHIAZIDE 107 91 24 49
BENAZEPRIL HCL 106 94 25 80
GLIMEPIRIDE 96 72 26 40
PREDNISONE 95 86 27 42
ATENOLOL 93 72 28 18
METOPROLOL SUCCINATE 93 78 28 19
TORSEMIDE 90 90 30 214
AMITRIPTYLINE HCL 89 61 R 31 46
VENLAFAXINE HCL 83 77 32 160
TAMSULOSIN HCL 80 71 33 26
RANITIDINE HCL 79 16 34 48
FLUTICASONE PROPIONATE 76 68 35 36
TRAZODONE HCL 72 52 36 31
CLOPIDOGREL 64 39 37 29
METHYLPREDNISOLONE 60 51 38 118
FINASTERIDE 59 59 39 115
BUSPIRONE HCL 59 52 39 119
AMIODARONE HCL 58 58 41 142
DIGOXIN 57 46 42 44
ESCITALOPRAM OXALATE 57 49 42 56
ATORVASTATIN CALCIUM 55 33 44 16
ALLOPURINOL 54 45 45 30
PROPRANOLOL HCL 54 51 45 111
FLUOXETINE HCL 54 33 45 57
PLAVIX 53 40 48 43
CRESTOR 51 45 49 34
DILTIAZEM HCL 51 40 49 177
DILTIAZEM ER 50 45 51 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.